Skip to main content

$0.120 0.010 (9.09%)

High

$0.12

Low

$0.11

Trades

74

Turnover

$139,612

Volume

1,216,523
30 June 2023 at 4:10pm
Register to track CAN and receive email alerts.
Subject
CAN Ann: Share Purchase Plan - offer opens

CAN Ann: Cleansing Statement - Share Purchase Plan

CAN Ann: Appendix 3H - Notification of Cessation of Securities

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Amended Quarterly Activities Report

CAN Ann: Quarterly Activities and Appendix 4C Cashflow Report

CAN Ann: Initial Director's Interest Notice - Dr Julian Chick

CAN Ann: Results of Annual General Meeting

CAN Ann: AGM presentation slides

CAN Ann: Chairman's and CEO's Addresses to Shareholders

CAN Ann: Share Purchase Plan

CAN Ann: Proposed issue of securities - CAN

CAN Ann: Cann receives $4.348m in R&D Tax incentive rebate

CAN Ann: Chief Executive Officer role update

CAN Ann: Clinical trial recruitment target met

CAN Ann: Scope of Mildura GMP licence extended

CAN Ann: Resignation and appointment of Company Secretary

CAN Ann: Change of address - corporate and registered office

CAN Ann: Appendix 3Y - Douglas Rathbone

CAN Ann: Notice of Annual General Meeting

CAN Ann: Initial Director's Interest Notice - Mr Robert Barnes

CAN Ann: Mr Robert Barnes & Dr Julian Chick appointed to the Board

CAN Ann: Final Director's Interest Notice

CAN Ann: Resignation of director

CAN Ann: Notice of date of AGM and other relevant dates

CAN Ann: Investor presentation - FY22 Results

CAN Ann: Appendix 4G & Corporate Governance Statement

CAN Ann: Cann releases FY22 results

CAN Ann: Appendix 4E & Annual Report to shareholders - FY22

CAN Ann: Upcoming investor presentation

CAN Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CAN Ann: Leasing facility secured from National Australia Bank

CAN Ann: GMP manufacturing licence granted for Mildura

CAN Ann: Cleansing notice regarding recent issues of shares

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Proposed issue of securities - CAN

CAN Ann: Notification of cessation of securities - CAN

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Notification regarding unquoted securities - CAN

CAN Ann: First commercial crop harvest underway at Mildura facility

CAN Ann: Cann receives payment from Regional Jobs Fund

CAN Ann: Notification regarding unquoted securities - CAN

CAN Ann: Monthly Activities/Appendix 4C Cash Flow Report

CAN Ann: New funding arrangements with National Australia Bank

CAN Ann: Commercial production update

CAN Ann: ODC manufacture permit granted for Mildura

CAN Ann: Evaluation and option agreement with GSK Consumer Healthcare

CAN Ann: Notification of cessation of securities - CAN

CAN Ann: Appendix 3G - lapse of options

CAN Ann: Satipharm CBD products get green light from UK FSA

Register to track CAN and receive email alerts.

Similar Companies

CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL